MedPath

Catheter ablation with power titration according to contact force in patients undergoing pulmonary vein isolatio

Not Applicable
Terminated
Conditions
Diseases of the circulatory system
Registration Number
KCT0002517
Lead Sponsor
Asan Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Terminated
Sex
All
Target Recruitment
100
Inclusion Criteria

1)Age =18 years, = 80 years
2)Atrial fibrillation, paroxysmal or persistent ( < 1 year in duration) which documented on the electrocardiography (12-lead electrocardiography, holter monitoring, or telemetry monitoring)
3)Refractory or intolerant to class I or III antiarrhythmic drug(s)
4) providing informed consent to radiofrequency ablation for atrial fibrillation

Exclusion Criteria

1) Atrial fibrillation from transient reversible cause
2) Coagulopathy
3) Pregnancy
4) Longstanding persistent atrial fibrillation ( >1 year)
5) Atypical atrial flutter
6) Prior catheter or surgical ablation of atrial fibrillation
7) Prior open heart surgery from any cause
8) Acute myocardial infarction, percutaneous coronary intervention, or coronary artery bypas grafting within 3 months
9) mitral or aortic valvular heart disease more than moderate degree
10) Large left atrial size (anterior-posterior diameter more than 50mm)
11) Presence of thrombus in left atrium or appendage
12) Significant hematologic disorder (leukocyte count < 3000/mm3, or thrombocytopenia < 100,000/mm3)
13) Significant liver dysfunction
14) Significant renal dysfunction
15) Contraindications to the anticoagulation
16) Left ventricular ejection fraction less than 45%
17) A patient who currently enrolled in other randomized clinical study (except registry)
18) A patient with other significant comorbidity whom is deemed not suitable to participate in the current study

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Presence of dormant conduction provoked with 12mg of intravenous adenosine injection after pulmonary vein isolation
Secondary Outcome Measures
NameTimeMethod
Recurrence of atrial fibrillation or flutter
© Copyright 2025. All Rights Reserved by MedPath